3Winer E, Gralow J, Diller L, et al. Clinical cancer advances 2008: major research advances in cancer treat- ment, prevention, and screening--a report from the American Society of Clinical Oncology [J]. J Clin Oncol, 2009, 27(5): 812-826.
4Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan [J]. J Natl Cancer Inst Monogr, 1997, (22): 27-30.
5Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial [J]. BMJ, 1988, 297(6654): 943-948.
6Warwick J, Tabar L, Vitak B, et al. Time-ependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study [J]. Cancer, 2004, 100(7): 1331-1336.
7Frisell J, Lidbrink E, Hellstrom L, et al. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial [J]. Breast Cancer Res Treat, 1997, 45(3): 263-270.
8Frisell J, Lidbrink E. The Stockholm Mammographic Screening Trial: risks and benefits in age group 40-49 years[J]. J Natl Cancer Inst Monogr, 1997(22): 49-51.
9BjurstamN, Bjorneld L, Warwick J, et al. The Gothenburg Breast Screening Trial[J]. Cancer,2003,97(10):2387-2396.
10Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breastcancer screening[J]. Lancet, 1999, 353(9168): 1903-1908.
